Global Acute Lung Injury Market Research Report 2023

Report ID: 1982924 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acute Lung Injury Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Pharmacotherapy
        1.2.3 Mechanical Ventilation
        1.2.4 Adjunctive Procedures
        1.2.5 Fluid Management
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Acute Lung Injury Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Acute Lung Injury Market Perspective (2017-2028)
    2.2 Acute Lung Injury Growth Trends by Region
        2.2.1 Acute Lung Injury Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Acute Lung Injury Historic Market Size by Region (2017-2022)
        2.2.3 Acute Lung Injury Forecasted Market Size by Region (2023-2028)
    2.3 Acute Lung Injury Market Dynamics
        2.3.1 Acute Lung Injury Industry Trends
        2.3.2 Acute Lung Injury Market Drivers
        2.3.3 Acute Lung Injury Market Challenges
        2.3.4 Acute Lung Injury Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Acute Lung Injury Players by Revenue
        3.1.1 Global Top Acute Lung Injury Players by Revenue (2017-2022)
        3.1.2 Global Acute Lung Injury Revenue Market Share by Players (2017-2022)
    3.2 Global Acute Lung Injury Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Acute Lung Injury Revenue
    3.4 Global Acute Lung Injury Market Concentration Ratio
        3.4.1 Global Acute Lung Injury Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acute Lung Injury Revenue in 2021
    3.5 Acute Lung Injury Key Players Head office and Area Served
    3.6 Key Players Acute Lung Injury Product Solution and Service
    3.7 Date of Enter into Acute Lung Injury Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Lung Injury Breakdown Data by Type
    4.1 Global Acute Lung Injury Historic Market Size by Type (2017-2022)
    4.2 Global Acute Lung Injury Forecasted Market Size by Type (2023-2028)
5 Acute Lung Injury Breakdown Data by Application
    5.1 Global Acute Lung Injury Historic Market Size by Application (2017-2022)
    5.2 Global Acute Lung Injury Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Acute Lung Injury Market Size (2017-2028)
    6.2 North America Acute Lung Injury Market Size by Country (2017-2022)
    6.3 North America Acute Lung Injury Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Acute Lung Injury Market Size (2017-2028)
    7.2 Europe Acute Lung Injury Market Size by Country (2017-2022)
    7.3 Europe Acute Lung Injury Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Acute Lung Injury Market Size (2017-2028)
    8.2 Asia-Pacific Acute Lung Injury Market Size by Country (2017-2022)
    8.3 Asia-Pacific Acute Lung Injury Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Acute Lung Injury Market Size (2017-2028)
    9.2 Latin America Acute Lung Injury Market Size by Country (2017-2022)
    9.3 Latin America Acute Lung Injury Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Acute Lung Injury Market Size (2017-2028)
    10.2 Middle East & Africa Acute Lung Injury Market Size by Country (2017-2022)
    10.3 Middle East & Africa Acute Lung Injury Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Altor BioScience
        11.1.1 Altor BioScience Company Detail
        11.1.2 Altor BioScience Business Overview
        11.1.3 Altor BioScience Acute Lung Injury Introduction
        11.1.4 Altor BioScience Revenue in Acute Lung Injury Business (2017-2022)
        11.1.5 Altor BioScience Recent Development
    11.2 FirstString Research
        11.2.1 FirstString Research Company Detail
        11.2.2 FirstString Research Business Overview
        11.2.3 FirstString Research Acute Lung Injury Introduction
        11.2.4 FirstString Research Revenue in Acute Lung Injury Business (2017-2022)
        11.2.5 FirstString Research Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Detail
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Acute Lung Injury Introduction
        11.3.4 GlaxoSmithKline Revenue in Acute Lung Injury Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Forschung und Entwicklung
        11.4.1 Forschung und Entwicklung Company Detail
        11.4.2 Forschung und Entwicklung Business Overview
        11.4.3 Forschung und Entwicklung Acute Lung Injury Introduction
        11.4.4 Forschung und Entwicklung Revenue in Acute Lung Injury Business (2017-2022)
        11.4.5 Forschung und Entwicklung Recent Development
    11.5 Commence Bio
        11.5.1 Commence Bio Company Detail
        11.5.2 Commence Bio Business Overview
        11.5.3 Commence Bio Acute Lung Injury Introduction
        11.5.4 Commence Bio Revenue in Acute Lung Injury Business (2017-2022)
        11.5.5 Commence Bio Recent Development
    11.6 CompleGen
        11.6.1 CompleGen Company Detail
        11.6.2 CompleGen Business Overview
        11.6.3 CompleGen Acute Lung Injury Introduction
        11.6.4 CompleGen Revenue in Acute Lung Injury Business (2017-2022)
        11.6.5 CompleGen Recent Development
    11.7 Histocell S.L.
        11.7.1 Histocell S.L. Company Detail
        11.7.2 Histocell S.L. Business Overview
        11.7.3 Histocell S.L. Acute Lung Injury Introduction
        11.7.4 Histocell S.L. Revenue in Acute Lung Injury Business (2017-2022)
        11.7.5 Histocell S.L. Recent Development
    11.8 Stemedica Cell Technologies
        11.8.1 Stemedica Cell Technologies Company Detail
        11.8.2 Stemedica Cell Technologies Business Overview
        11.8.3 Stemedica Cell Technologies Acute Lung Injury Introduction
        11.8.4 Stemedica Cell Technologies Revenue in Acute Lung Injury Business (2017-2022)
        11.8.5 Stemedica Cell Technologies Recent Development
    11.9 Windtree Therapeutics
        11.9.1 Windtree Therapeutics Company Detail
        11.9.2 Windtree Therapeutics Business Overview
        11.9.3 Windtree Therapeutics Acute Lung Injury Introduction
        11.9.4 Windtree Therapeutics Revenue in Acute Lung Injury Business (2017-2022)
        11.9.5 Windtree Therapeutics Recent Development
    11.10 S-Evans Biosciences
        11.10.1 S-Evans Biosciences Company Detail
        11.10.2 S-Evans Biosciences Business Overview
        11.10.3 S-Evans Biosciences Acute Lung Injury Introduction
        11.10.4 S-Evans Biosciences Revenue in Acute Lung Injury Business (2017-2022)
        11.10.5 S-Evans Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Acute Lung Injury Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Pharmacotherapy
    Table 3. Key Players of Mechanical Ventilation
    Table 4. Key Players of Adjunctive Procedures
    Table 5. Key Players of Fluid Management
    Table 6. Key Players of Others
    Table 7. Global Acute Lung Injury Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Acute Lung Injury Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Acute Lung Injury Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Acute Lung Injury Market Share by Region (2017-2022)
    Table 11. Global Acute Lung Injury Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Acute Lung Injury Market Share by Region (2023-2028)
    Table 13. Acute Lung Injury Market Trends
    Table 14. Acute Lung Injury Market Drivers
    Table 15. Acute Lung Injury Market Challenges
    Table 16. Acute Lung Injury Market Restraints
    Table 17. Global Acute Lung Injury Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Acute Lung Injury Market Share by Players (2017-2022)
    Table 19. Global Top Acute Lung Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Lung Injury as of 2021)
    Table 20. Ranking of Global Top Acute Lung Injury Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Acute Lung Injury Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Acute Lung Injury Product Solution and Service
    Table 24. Date of Enter into Acute Lung Injury Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Acute Lung Injury Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Acute Lung Injury Revenue Market Share by Type (2017-2022)
    Table 28. Global Acute Lung Injury Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Acute Lung Injury Revenue Market Share by Type (2023-2028)
    Table 30. Global Acute Lung Injury Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Acute Lung Injury Revenue Market Share by Application (2017-2022)
    Table 32. Global Acute Lung Injury Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Acute Lung Injury Revenue Market Share by Application (2023-2028)
    Table 34. North America Acute Lung Injury Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Acute Lung Injury Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Acute Lung Injury Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Acute Lung Injury Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Acute Lung Injury Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Acute Lung Injury Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Acute Lung Injury Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Acute Lung Injury Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Acute Lung Injury Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Acute Lung Injury Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Altor BioScience Company Detail
    Table 45. Altor BioScience Business Overview
    Table 46. Altor BioScience Acute Lung Injury Product
    Table 47. Altor BioScience Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 48. Altor BioScience Recent Development
    Table 49. FirstString Research Company Detail
    Table 50. FirstString Research Business Overview
    Table 51. FirstString Research Acute Lung Injury Product
    Table 52. FirstString Research Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 53. FirstString Research Recent Development
    Table 54. GlaxoSmithKline Company Detail
    Table 55. GlaxoSmithKline Business Overview
    Table 56. GlaxoSmithKline Acute Lung Injury Product
    Table 57. GlaxoSmithKline Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 58. GlaxoSmithKline Recent Development
    Table 59. Forschung und Entwicklung Company Detail
    Table 60. Forschung und Entwicklung Business Overview
    Table 61. Forschung und Entwicklung Acute Lung Injury Product
    Table 62. Forschung und Entwicklung Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 63. Forschung und Entwicklung Recent Development
    Table 64. Commence Bio Company Detail
    Table 65. Commence Bio Business Overview
    Table 66. Commence Bio Acute Lung Injury Product
    Table 67. Commence Bio Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 68. Commence Bio Recent Development
    Table 69. CompleGen Company Detail
    Table 70. CompleGen Business Overview
    Table 71. CompleGen Acute Lung Injury Product
    Table 72. CompleGen Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 73. CompleGen Recent Development
    Table 74. Histocell S.L. Company Detail
    Table 75. Histocell S.L. Business Overview
    Table 76. Histocell S.L. Acute Lung Injury Product
    Table 77. Histocell S.L. Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 78. Histocell S.L. Recent Development
    Table 79. Stemedica Cell Technologies Company Detail
    Table 80. Stemedica Cell Technologies Business Overview
    Table 81. Stemedica Cell Technologies Acute Lung Injury Product
    Table 82. Stemedica Cell Technologies Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 83. Stemedica Cell Technologies Recent Development
    Table 84. Windtree Therapeutics Company Detail
    Table 85. Windtree Therapeutics Business Overview
    Table 86. Windtree Therapeutics Acute Lung Injury Product
    Table 87. Windtree Therapeutics Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 88. Windtree Therapeutics Recent Development
    Table 89. S-Evans Biosciences Company Detail
    Table 90. S-Evans Biosciences Business Overview
    Table 91. S-Evans Biosciences Acute Lung Injury Product
    Table 92. S-Evans Biosciences Revenue in Acute Lung Injury Business (2017-2022) & (US$ Million)
    Table 93. S-Evans Biosciences Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Lung Injury Market Share by Type: 2021 VS 2028
    Figure 2. Pharmacotherapy Features
    Figure 3. Mechanical Ventilation Features
    Figure 4. Adjunctive Procedures Features
    Figure 5. Fluid Management Features
    Figure 6. Others Features
    Figure 7. Global Acute Lung Injury Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Acute Lung Injury Report Years Considered
    Figure 12. Global Acute Lung Injury Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Acute Lung Injury Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Acute Lung Injury Market Share by Region: 2021 VS 2028
    Figure 15. Global Acute Lung Injury Market Share by Players in 2021
    Figure 16. Global Top Acute Lung Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Lung Injury as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Acute Lung Injury Revenue in 2021
    Figure 18. North America Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Acute Lung Injury Market Share by Country (2017-2028)
    Figure 20. United States Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Acute Lung Injury Market Share by Country (2017-2028)
    Figure 24. Germany Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Acute Lung Injury Market Share by Region (2017-2028)
    Figure 32. China Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Acute Lung Injury Market Share by Country (2017-2028)
    Figure 40. Mexico Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Acute Lung Injury Market Share by Country (2017-2028)
    Figure 44. Turkey Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Acute Lung Injury Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Altor BioScience Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 47. FirstString Research Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 49. Forschung und Entwicklung Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 50. Commence Bio Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 51. CompleGen Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 52. Histocell S.L. Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 53. Stemedica Cell Technologies Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 54. Windtree Therapeutics Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 55. S-Evans Biosciences Revenue Growth Rate in Acute Lung Injury Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Altor BioScience
FirstString Research
GlaxoSmithKline
Forschung und Entwicklung
Commence Bio
CompleGen
Histocell S.L.
Stemedica Cell Technologies
Windtree Therapeutics
S-Evans Biosciences
Frequently Asked Questions
Acute Lung Injury report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Lung Injury report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Lung Injury report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Acyclovir

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More